Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “FDG-PET/CT”

Showing 20 of 0 results

Not applicableStudy completedNCT00590395
What this trial is testing

FDG-PET/CT in the Evaluation of Patients With Suspected Cholecystitis

Who this might be right for
Cholecystitis
Alan D. Waxman, M.D. 19
Not applicableStudy completedNCT04163276
What this trial is testing

Database of Positon Emission Tomography (PET) Digital Brain Exams, in 50th Age of Patients

Who this might be right for
Neurodegenerative Diseases
Central Hospital, Nancy, France 80
Post-approval studies (Phase 4)Study completedNCT02811185
What this trial is testing

Registry Type Study to Monitor for Adverse Drug Reactions to Fedoruk Manufactured [F-18]-Fludeoxyglucose

Who this might be right for
Positron-Emission Tomography and Cone-Beam Computed Tomography
University of Saskatchewan 1,012
Not applicableStudy completedNCT00833625
What this trial is testing

FDG-PET-CT and Biomarkers in Esophageal Cancer

Who this might be right for
Gastrointestinal DiseaseEsophageal Cancer
M.D. Anderson Cancer Center 31
Not applicableStudy completedNCT03409913
What this trial is testing

Diagnostic Accuracy of FDG PET/CT of Cranial Arteries in GCA

Who this might be right for
Giant Cell Arteritis
University of Aarhus 106
Not applicableUnknownNCT03517306
What this trial is testing

PET/CT Based Radiomics for Lung Cancer (PERL)

Who this might be right for
Lung Cancer
Second Affiliated Hospital of Wenzhou Medical University 1,500
Not applicableStudy completedNCT01664936
What this trial is testing

Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes

Who this might be right for
Head and Neck Cancers
Memorial Sloan Kettering Cancer Center 27
Not applicableStudy completedNCT06945432
What this trial is testing

Comparing 68Ga-CTR-FAPI and 18F-FDG PET/ CT in Cancer Detection

Who this might be right for
TumorsPET / CTFDG PET/CT+1 more
Lanzhou University Second Hospital 27
Not applicableEnded earlyNCT02716077
What this trial is testing

Early FDG PET in Melanoma

Who this might be right for
Clinical Stage III Nodal or Intransit Disease or Resectable Stage IV Melanoma
Abramson Cancer Center at Penn Medicine 6
Not applicableUnknownNCT04931875
What this trial is testing

Total-body PET / CT in the Evaluation of Treatment and Prognosis of Lymphoma

Who this might be right for
Lymphoma
RenJi Hospital 100
Not applicableNot Yet RecruitingNCT05531045
What this trial is testing

18FFDG PET/CT for Early Evaluation of Chemotherapy Efficacy in Metastatic Colic Adenocarcinoma

Who this might be right for
Metastatic Colorectal Cancer
Assistance Publique - Hôpitaux de Paris 222
Not applicableUnknownNCT01292681
What this trial is testing

Multi-modality Imaging in the Prediction of Response to Systemic Treatment in Colorectal Cancer

Who this might be right for
Colorectal Cancer
Radboud University Medical Center 60
Very early researchStudy completedNCT00620243
What this trial is testing

Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.

Who this might be right for
Ovarian Cancer
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Ended earlyNCT02325349
What this trial is testing

PET/CT Imaging of Angiogenesis in Lung or Head and Neck Cancers Prior or During Chemotherapy With Antiangiogenic Agents

Who this might be right for
Advanced Head and Neck CarcinomaAdvanced Non-small Cell Lung Carcinoma
Assistance Publique - Hôpitaux de Paris 1
Testing effectiveness (Phase 2)UnknownNCT01083719
What this trial is testing

A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.

Who this might be right for
Glioblastoma
Medanta Institute of Clinical Research 15
Not applicableLooking for participantsNCT07750470
What this trial is testing

Diagnostic Accuracy of 18F-FDG PET/CT in Muscle-invasive Bladder Cancer

Who this might be right for
Muscle-invasive Bladder Cancer
University Hospital of Ferrara 60
Not applicableStudy completedNCT02528695
What this trial is testing

Adipose Tissue Imaging in Type 2 Diabetes

Who this might be right for
Diabetes Mellitus Type 2
Radboud University Medical Center 15
Not applicableStudy completedNCT03841175
What this trial is testing

Forecasts Impact of the Pre-therapeutic TEP-TDM in the 18-FDG Restaging of Upper Aero-digestive Tract Cancers

Who this might be right for
Cancer of Head and Neck
University Hospital, Brest 477
Not applicableUnknownNCT01330186
What this trial is testing

Predictive Value of FMISO-PET, FDG-PET-CT, DWI-MRI and DCE-MRI Scans for Patients With Anal Cancer Receiving Radiotherapy +/- Chemotherapy

Who this might be right for
Anal Cancer
Copenhagen University Hospital at Herlev 50
Not applicableStudy completedNCT02909075
What this trial is testing

Assess Thymic Function Using PET/CT and MRI

Who this might be right for
CD34 Selected Peripheral Blood Stem Cell Graft
Memorial Sloan Kettering Cancer Center 3
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation